KRTAP8-1 Inhibitors
KRTAP8-1 inhibitors refer to a class of compounds that target the keratin-associated protein 8-1 (KRTAP8-1), a member of the keratin-associated protein (KRTAP) family involved in the structural integrity of hair and wool fibers. These proteins contribute to the formation of the disulfide-rich matrix that surrounds keratin intermediate filaments, thus playing a crucial role in hair structure and strength. Inhibitors of KRTAP8-1 can modulate the interaction between keratin proteins and the surrounding matrix, potentially affecting the physical properties of keratinized tissues such as hair, nails, and skin.
Chemically, KRTAP8-1 inhibitors may belong to various classes of small molecules or larger biomolecules that can specifically bind to KRTAP8-1 or alter its conformational state. These inhibitors could act by disrupting the protein's folding, binding, or polymerization interactions with keratin intermediate filaments. The specificity of KRTAP8-1 inhibitors may arise from their structural complementarity to KRTAP8-1 binding sites, or from their ability to interfere with post-translational modifications, such as disulfide bond formation. While the chemical structures of these inhibitors can vary widely, common features may include functionalities that enable them to interact with cysteine residues, key components in disulfide bond formation. Understanding the exact mechanism of these inhibitors requires detailed study of the KRTAP8-1 protein's structure and function, as well as the molecular dynamics that regulate its interactions with keratins.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine could reduce KRTAP8-1 expression by incorporating into DNA where it would trap DNA methyltransferases, leading to DNA demethylation and transcriptional repression of the gene. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A may decrease KRTAP8-1 expression by inhibiting histone deacetylase activity, causing hyperacetylation of histones, which could lead to the closing of chromatin conformation around the KRTAP8-1 gene locus. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A can inhibit the transcription of KRTAP8-1 by binding to its gene promoter region, obstructing the necessary transcription factors from initiating gene transcription. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D may decrease KRTAP8-1 expression by intercalating into DNA and preventing the advancement of RNA polymerase along the DNA template at the transcriptional start site of the KRTAP8-1 gene. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
5-Aza-2′-Deoxycytidine could downregulate KRTAP8-1 expression by demethylating cytosines in the DNA of its promoter region, which could interfere with the recruitment of methyl-CpG-binding domain proteins and transcription repressors. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid may lead to a decrease in KRTAP8-1 expression by inhibiting the removal of acetyl groups from histones, particularly at the promoter region of the KRTAP8-1 gene, preventing the assembly of transcriptional machinery. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid could downregulate KRTAP8-1 expression by binding to its retinoic acid response elements if present within the gene's promoter, recruiting co-repressor complexes which silence gene transcription. | ||||||
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $109.00 | 3 | |
Spironolactone may inhibit KRTAP8-1 expression by blocking androgen receptors, which if involved in the gene's expression, would decrease the transcriptional activation of KRTAP8-1 in response to androgenic hormones. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein could reduce KRTAP8-1 expression by inhibiting the activity of specific tyrosine kinases, leading to decreased phosphorylation of transcription factors that drive the expression of KRTAP8-1. | ||||||
Finasteride | 98319-26-7 | sc-203954 | 50 mg | $105.00 | 3 | |
Finasteride could decrease KRTAP8-1 expression by inhibiting the enzyme 5-alpha reductase, reducing the production of dihydrotestosterone which might otherwise enhance the gene's transcription. | ||||||